SURI vs. SBIO ETF Comparison

Comparison of Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI) to ALPS Medical Breakthroughs ETF (SBIO)
SURI

Simplify Exchange Traded Funds Simplify Propel Opportunities ETF

SURI Description

The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$23.04

Average Daily Volume

5,481

Number of Holdings *

15

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$37.19

Average Daily Volume

8,401

Number of Holdings *

83

* may have additional holdings in another (foreign) market
Performance
Period SURI SBIO
30 Days -2.76% -5.42%
60 Days -1.68% -4.19%
90 Days 2.36% 2.30%
12 Months 42.14% 47.72%
6 Overlapping Holdings
Symbol Grade Weight in SURI Weight in SBIO Overlap
AKRO C 6.84% 1.32% 1.32%
APLT B 24.2% 0.72% 0.72%
CMPS F 0.56% 0.23% 0.23%
KURA F 1.3% 0.83% 0.83%
RNA C 5.13% 3.29% 3.29%
SNDX F 1.47% 0.93% 0.93%
SURI Overweight 9 Positions Relative to SBIO
Symbol Grade Weight
PAGP A 21.27%
PHAT F 8.7%
MDGL C 5.87%
ARDX F 3.93%
TSAT D 1.83%
KYMR D 1.37%
ACHV F 0.99%
ATHA D 0.62%
VRCA F 0.27%
SURI Underweight 77 Positions Relative to SBIO
Symbol Grade Weight
CORT B -3.66%
KRYS C -3.39%
ACLX C -3.19%
ALKS C -3.15%
CRNX B -2.95%
IMVT F -2.66%
DNLI D -2.36%
MRUS F -2.21%
AGIO C -2.05%
PTCT B -2.02%
XENE D -2.01%
VRNA A -1.98%
FOLD F -1.95%
EWTX C -1.92%
ACAD C -1.89%
VERA C -1.82%
ZLAB C -1.79%
VCEL A -1.73%
PTGX D -1.61%
CGON F -1.57%
IDYA F -1.53%
GERN C -1.48%
MIRM B -1.47%
KROS D -1.4%
LBPH A -1.4%
MNKD B -1.26%
IRON B -1.21%
GLPG F -1.19%
TARS C -1.16%
IMCR C -1.07%
CLDX D -1.06%
ARVN F -1.06%
BCRX D -0.99%
XNCR B -0.98%
RCUS F -0.95%
NTLA F -0.94%
SPRY C -0.88%
VRDN D -0.84%
DAWN D -0.82%
AUPH C -0.78%
PHVS D -0.76%
COGT D -0.69%
ETNB D -0.57%
LQDA F -0.54%
PLRX D -0.53%
PRTA F -0.52%
ERAS C -0.51%
REPL C -0.5%
IRWD F -0.44%
AVXL B -0.42%
ANNX F -0.4%
MLYS F -0.39%
ALT C -0.37%
OLMA F -0.37%
ANAB F -0.36%
FLGT F -0.35%
ALLO F -0.35%
CELC F -0.34%
YMAB F -0.34%
URGN F -0.34%
SVRA F -0.34%
FULC F -0.33%
TBPH B -0.32%
FDMT F -0.31%
GHRS B -0.31%
ARCT F -0.31%
AURA C -0.3%
ALEC F -0.28%
ACIU D -0.22%
VNDA C -0.2%
ITOS F -0.19%
STRO F -0.17%
ALDX D -0.17%
ZNTL D -0.17%
ENTA F -0.14%
INZY F -0.12%
HLVX F -0.06%
Compare ETFs